Edition:
United States

Hubei Yangfan Holding Co Ltd (600421.SS)

600421.SS on Shanghai Stock Exchange

12.39CNY
1:59am EST
Change (% chg)

¥-0.09 (-0.72%)
Prev Close
¥12.48
Open
¥12.40
Day's High
¥12.42
Day's Low
¥12.31
Volume
327,755
Avg. Vol
986,257
52-wk High
¥30.00
52-wk Low
¥11.72

Summary

Name Age Since Current Position

Weixing Zhou

53 2013 Chairman of the Board

Lihua Huang

45 2010 Chief Financial Officer

Bo Jiang

53 2012 General Manager

Bin Zhang

40 2013 Executive Deputy General Manager

Caibing Wen

44 2013 Secretary of the Board

Hanxin Qian

60 2009 Director

Zuchang Teng

48 2009 Director

Zhongliang Zhu

60 2009 Director

Wei Hua

44 2010 Independent Director

Di Li

56 2010 Independent Director

Jun Xu

44 2009 Independent Director

Biographies

Name Description

Weixing Zhou

Mr. Zhou Weixing has been serving as Chairman of the Board in Wuhan National Pharmaceutical Technology Co., Ltd. since April 1, 2013. He also serves as Vice President and Head of General Office in a Shanghai-based group company. He served as Deputy General Manager in the Company, as well as Executive Deputy General Manager in an industrial company, and Chairman of the Board in a Henan-based group company.

Lihua Huang

Ms. Huang Lihua has been serving as Chief Financial Officer in Wuhan National Pharmaceutical Technology Co., Ltd. since April 25, 2010. She served as Finance Manager in a Shanghai-based group company.

Bo Jiang

Mr. Jiang Bo has been General Manager in Wuhan National Pharmaceutical Technology Co. Ltd since March 2, 2012. He used to be Deputy General Manager in a Shanghai-based investment company, as well as General Manager in a Shanghai-based hotel.

Bin Zhang

Mr. Zhang Bin has been serving as Executive Deputy General Manager in Wuhan National Pharmaceutical Technology Co., Ltd. since April 1, 2013. He served as Deputy General Manager and Secretary of the Board in a Xiamen-based technology group company.

Caibing Wen

Mr. Wen Caibing has been serving as Secretary of the Board in Wuhan National Pharmaceutical Technology Co., Ltd. since April 1, 2013. He holds a Master's degree.

Hanxin Qian

Mr. Qian Hanxin has been Director of Wuhan National Pharmaceutical Technology Co., Ltd. since October 10, 2009. He also serves as Chairman of the Board in a Wuhan-based technology company. Previously, he was General Manager, Executive Director and Chairman of the Board of other companies.

Zuchang Teng

Mr. Teng Zuchang has been Director of Wuhan National Pharmaceutical Technology Co. Ltd. since October 10, 2009. He currently serves as General Manager of a Shanghai-based group company, as well as Director of Panda Wire & Cable Co., Ltd. He used to be Deputy General Manager, General Manager, Director and Chairman of the Board in other companies.

Zhongliang Zhu

Mr. Zhu Zhongliang has been Director of Wuhan National Pharmaceutical Technology Co. Ltd. since October 10, 2009. He currently also serves as Executive Deputy General Manager of two other companies. He used to be Chairman of the Board and Deputy General Manager of two other companies.

Wei Hua

Mr. Hua Wei has been Independent Director of Wuhan National Pharmaceutical Technology Co. Ltd. since February 8, 2010. He is also Independent Director in Tibet Urban Development and Investment Co., LTD.

Di Li

Mr. Li Di has been Independent Director of Wuhan National Pharmaceutical Technology Co. Ltd. since February 8, 2010. He was Independent Director of an investment company.

Jun Xu

Mr. Xu Jun has been Independent Director of Wuhan National Pharmaceutical Technology Co. Ltd. since October 10, 2009. He currently also serves as Independent Director of Shanghai Yimin Commercial Co., Ltd.

Basic Compensation

Name Fiscal Year Total

Weixing Zhou

120,000

Lihua Huang

--

Bo Jiang

20,000

Bin Zhang

--

Caibing Wen

84,000

Hanxin Qian

--

Zuchang Teng

--

Zhongliang Zhu

--

Wei Hua

50,000

Di Li

50,000

Jun Xu

50,000
As Of  30 Dec 2011